Home Public Opinion Topics

Public Opinion

THE MIDTERMS

KFF Health Tracking Poll: MAHA and the Midterms

Chemical food additive and pesticide concerns associated with the Make America Health Again (MAHA) movement are shared broadly across the public. But when it comes to voters, health care costs are a higher priority and bigger motivator, even among MAHA supporters, a new KFF Health Tracking Poll finds. When asked to identify their most important health priority for government to address, far more MAHA-supporting voters identify lowering the cost of health care (42%) than other issues more closely associated with the movement.

For more on this topic, read KFF Founding President and CEO Dr. Drew Altman's new Beyond the Data column: There Are Many MAHAs.

Poll: Health Care Costs and the Midterms

Health care costs continue to top the public’s list of affordability worries, even as concerns about gas prices have risen in recent weeks, with two-thirds of the public expressing worry over affording health care costs.

Americans’ Challenges with Health Care Costs

This data note reviews our recent polling data that finds that many Americans struggle to afford many aspects of health care, including disproportionate shares of uninsured adults, Black and Hispanic adults and those with lower incomes.

Health Information and Trust

Dashboard: Polling on Health Information and Trust

Drawing on KFF’s poll findings, this interactive dashboard tracks the public’s trusted sources for health information, attitudes toward vaccines, and use of news, social media, and AI for health-related information.

Recent Polls

Public Views on Foreign Aid and Global Health

This poll finds that less than half of the public now wants the U.S. to play at least a major role in improving the health of people in developing countries. When asked about the administration’s changes to foreign aid and global health, more people perceive a negative impact than a positive one.

Knowledge and Views of Medication Abortion

This KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.

KFF/New York Times Survey of Immigrants

KFF-New York Times Survey: Immigrants Report Rising Fear, Negative Economic and Health Impacts, and Changing Political Views During the First Year of President Trump’s Second Term

The 2025 Survey of Immigrants, a partnership between KFF and The New York Times, takes an in-depth look at the experiences of immigrants during the first year of President Trump’s second term, including their worries related to increased immigration enforcement, their health and economic wellbeing, and the political views and preferences of immigrant voters. The survey paints a portrait of families under strain — where fear of detention and economic instability are negatively impacting immigrants’ health and reshaping immigrant families’ daily lives and views of U.S. political parties.

Read the News Release | Explore The New York Times’ Reporting

the essentials

Health Tracking Poll

Our signature survey project provides up-to-date data on the public’s health care views, knowledge, and experiences.

Tracking the Public’s Views on the ACA

Tracking the Public’s Views on the ACA

This interactive tool tracks public opinion on the Affordable Care Act, from the inception of the law to the present, including trends based on party identification, income, age, gender, and race/ethnicity.

Health Information and Trust Tracking Poll

The Health Information and Trust Tracking Poll is part of KFF’s Health Information and Trust Initiative, which tracks health misinformation and analyzes its impact on the public.

Polls in Health Policy

This chapter of our digital “textbook” explores why surveys are essential for understanding health policy issues. 

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Public Opinion

Filter

List Grid

781 - 790 of 1,840 Results

  • The Good and Bad of Those Ubiquitous Drug Ads

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new survey.

  • Kaiser Health Tracking Poll: October 2015

    Feature

    This month’s Kaiser Health Tracking Poll finds that the affordability of prescription drugs continues to be at the top of the public’s priority list for the President and Congress, picked by majorities across political parties. Issues specific to the ACA, such as repealing provisions of the law or repealing the law entirely, fall much lower on the list. The survey also probes the public's experiences with drug advertisements. A large majority (82%) report they’ve seen…

  • Prescription Drug Costs Remain Atop the Public’s National Health Care Agenda, Well Ahead of Affordable Care Act Revisions and Repeal

    News Release

    28% of Public Report Asking Doctor about a Drug They Saw Advertised, and 12% Say Their Doctor Prescribed It Few Workers Expect Raises if Employers Reduce Health Benefits to Avoid Cadillac Tax as Many Economists Predict With some presidential candidates laying out details of their health care platforms, the cost of prescription drugs remains at the top of the public's health care priority list for the President and Congress, the October Kaiser Health Tracking Poll…

  • Kaiser Health Tracking Poll: September 2015

    Feature

    As the Centers for Medicare & Medicaid Services prepares to finalize a plan to pay physicians for discussing end-of-life treatment options with Medicare patients, this month’s Kaiser Health Tracking Poll finds that about 8 in 10 of the public favors Medicare and private insurance covering such discussions and about 9 in 10 say doctors should have these discussions with their patients. However, relatively few (17 percent) say they’ve had such discussions with a doctor or other…

  • Public Strongly Favors End-of-Life Conversations Between Doctors and Patients, With About Eight in 10 Saying Medicare and Other Insurers Should Cover These Visits

    News Release

    Six in 10 Oppose 'Cadillac Plan Tax' on High-Cost Health Plans Set to Take Effect in 2018, But Cost Savings Argument Can Change Some Opinions Views on the Affordable Care Act Remain Divided: 45% Unfavorable, 41% Favorable As the Centers for Medicare & Medicaid Services prepares to finalize a plan to pay physicians for discussing end-of-life treatment options with Medicare patients, the latest Kaiser Health Tracking Poll finds an overwhelming majority supports such coverage. The…

  • How Primary-Care Physicians Are Handling the Influx of Newly Insured

    News Release

    In his column for The Wall Street Journal's Think Tank, Kaiser’s President Drew Altman is joined by The Commonwealth Fund's President David Blumenthal to discuss the impact of the Affordable Care Act’s coverage expansion on the primary care delivery system. Their analysis is based on the Kaiser-Commonwealth National Survey of Primary Care Providers. All previous columns by Drew Altman are available online.  

  • How Primary-Care Physicians Are Handling the Influx of Newly Insured

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Kaiser’s President Drew Altman is joined by The Commonwealth Fund's President David Blumenthal to discuss the impact of the Affordable Care Act’s coverage expansion on the primary care delivery system.

  • Why Higher Drug Costs Are Consumers’ Biggest Cost Worry

    News Release

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs. All previous columns by Drew Altman are available online.

  • Why Higher Drug Costs Are Consumers’ Biggest Cost Worry

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs.

  • Will GOP Candidates’ Positions on Obamacare Matter in Crowded Field?

    News Release

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman analyzes the politics of Republican Affordable Care Act replacement plans and the challenges all Republican candidates will face distinguishing themselves from others on the ACA in a crowded primary field. All previous columns by Drew Altman are available online.